Karen A. Dawes, Director at REPLIGEN CORP (RGEN), sold 517 shares at $140.29 ($72K) on 2020-05-20, disclosed to the SEC on 2020-05-21.
Seasonal sale ($72k) by Director — this insider has traded RGEN in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $135.91 | 10 | $1K | 1.9% |
| 2 | $136.98 | 43 | $6K | 8.2% |
| 3 | $139.40 | 282 | $39K | 54.5% |
| 4 | $140.29 | 182 | $26K | 35.4% |
| Total | $139.44 avg | 517 | $72K | 100% |
| Filing → |
| RGEN | SELL | 2023-08-30 | $146K | — | Filing → |
| RGEN | SELL | 2022-09-09 | $352K | — | Filing → |
| RGEN | SELL | 2022-05-26 | $4.4M | — | Filing → |